Fuad Ahmad Net Worth

The estimated Net Worth of Fuad Ahmad is at least 153 千$ dollars as of 22 June 2022. Fuad Ahmad owns over 5,000 units of Vaxart Inc stock worth over 4,700$ and over the last 17 years Fuad sold VXRT stock worth over 147,818$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Fuad Ahmad VXRT stock SEC Form 4 insiders trading

Fuad has made over 3 trades of the Vaxart Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Fuad bought 5,000 units of VXRT stock worth 16,100$ on 22 June 2022.

The largest trade Fuad's ever made was selling 17,000 units of Vaxart Inc stock on 17 July 2017 worth over 143,820$. On average, Fuad trades about 1,208 units every 95 days since 2007. As of 22 June 2022 Fuad still owns at least 5,000 units of Vaxart Inc stock.

You can see the complete history of Fuad Ahmad stock trades at the bottom of the page.

What's Fuad Ahmad's mailing address?

Fuad's mailing address filed with the SEC is C/O VAXART, INC., 170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Vaxart Inc

Over the last 7 years, insiders at Vaxart Inc have traded over 322,706,538$ worth of Vaxart Inc stock and bought 8,979,091 units worth 2,899,807$ . The most active insiders traders include Capital, Llc Armistice Capi...、Steven Lo、Wouter Latour. On average, Vaxart Inc executives and independent directors trade stock every 57 days with the average trade being worth of 1,309,363$. The most recent stock trade was executed by W. Mark Watson on 18 June 2024, trading 20,000 units of VXRT stock currently worth 13,600$.

What does Vaxart Inc do?

since its founding in 2004, vaxart has pursued a vision of advancing vaccines—to make them as tablets rather than injections. the company’s proprietary oral vaccine delivery platform is suitable to deliver any recombinant vaccine, positioning vaxart to introduce oral forms of multiple vaccines in the rapidly growing global vaccines market.

Complete history of Fuad Ahmad stock trades at Globalstar、Vaxart Inc

Vaxart Inc executives and stock owners

Vaxart Inc executives and other stock owners filed with the SEC include:

• Wouter Latour,
  Chairman of the Board
• Cezar Andrei Floroiu M.B.A.,
  CEO, Pres, Principal Financial Officer & Director
• Dr. Sean N. Tucker,
  Sr. VP & Chief Scientific Officer
• Margaret A. Echerd,
  Sr. VP & Principal Accounting Officer
• Sean Tucker,
  Chief Scientific Officer
• Margaret Echerd,
  Principal Accounting Officer, Vice President, Controller
• Anne VanLent,
  Independent Director
• Michael Finney,
  Independent Director
• Robert Yedid,
  Lead Independent Director
• Todd Davis,
  Independent Director
• Karen Wilson,
  Independent Director
• Keith Maher,
  Director
• Steven Boyd,
  Director
• Andrei Floroiu,
  Chief Executive Officer, Principal Financial Officer, Director
• Edward B. Berg,
  Sr. VP & Gen. Counsel
• John M. Harland M.B.A., CPA,
  Consultant
• Dr. James F. Cummings M.D.,
  Chief Medical Officer
• Dr. Rajesh Kapoor Ph.D.,
  Sr. VP of Quality
• Dr. Richard M. Schwartz,
  Sr. VP of Technical Operations
• Brant Biehn,
  Sr. VP of Bus. Operations
• Shaily Jaini Garg,
  Sr. VP of Clinical Devel. & Project Management
• Julie M Cherrington,
  Director
• Edward B Berg,
  SVP, General Counsel
• John M Harland,
  Chief Financial Officer
• Richard J Markham,
  Director
• Geoffrey F Cox,
  Director
• John P Richard,
  Director
• Phillip E Lee,
  Chief Financial Officer
• David E. Wheadon,
  Director
• James F. Cummings,
  Chief Medical Officer
• W. Mark Watson,
  Director
• Elaine J Heron,
  Director
• Steven Lo,
  President, Chief Exec Officer
• Fuad Ahmad,
  Interim CFO